Chimeric Antigen Receptor T Cell Therapy For Solid Tumors
Chimeric antigen receptor T (CAR T) cell therapy has revolutionized the management of lymphoid malignancies. However, it is still in its early phase and is facing many obstacles in solid tumors. Therapeutic challenges in solid tumor lead to tumor target diversification and drive new innovations for...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wolters Kluwer Medknow Publications
2022-07-01
|
| Серии: | Hematology/Oncology and Stem Cell Therapy |
| Предметы: | |
| Online-ссылка: | https://journals.lww.com/10.56875/2589-0646.1028 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|